The dawn of robotic surgery in otolaryngology-head and neck surgery.


Journal

Japanese journal of clinical oncology
ISSN: 1465-3621
Titre abrégé: Jpn J Clin Oncol
Pays: England
ID NLM: 0313225

Informations de publication

Date de publication:
01 May 2019
Historique:
received: 26 12 2018
revised: 14 01 2019
accepted: 30 01 2019
pubmed: 24 2 2019
medline: 10 8 2019
entrez: 24 2 2019
Statut: ppublish

Résumé

Transoral robotic surgery (TORS) utilizing the da Vinci robotic system has opened a new era for minimally-invasive surgery (MIS) in Otolaryngology-Head and Neck Surgery. Awareness of the historical steps in developing robotic surgery (RS) and understanding its current application within our field can help open our imaginations to future of the surgical robotics. We compiled a historical perspective on the evolution of surgical robotics, the road to the da Vinci surgical system, and conducted a review of TORS regarding clinical applications and limitations, prospective clinical trials and current status in Japan. We also provided commentary on the future of surgical robotics within our field. Surgical robotics grew out of the pursuit of telerobotics and the advances in robotics for non-medical applications. Today in our field, cancers and diseases of oropharynx and supraglottis are the most common indications for RS. It has proved capable of preserving the laryngopharyngeal function without compromising oncologic outcomes, and reducing the intensity of adjuvant therapy. TORS has become a standard modality for MIS, and will continue to evolve in the future. As robotic surgical systems evolve with improved capabilities in visual augmentation, spatial navigation, miniaturization, force-feedback and cost-effectiveness, we will see further advances in the current indications, and an expansion of indications. By promoting borderless international collaborations that put 'patients first', the bright future of surgical robotics will synergistically expand to the limits of our imaginations.

Identifiants

pubmed: 30796834
pii: 5364076
doi: 10.1093/jjco/hyz020
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

404-411

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Meijin Nakayama (M)

Department of Otorhinolaryngology-Head and Neck Surgery, Yokohama City University, Yokohama, Japan.

F Christopher Holsinger (FC)

Department of Otolaryngology, Division of Head and Neck Surgery, Stanford University, Palo Alto, California, USA.

Dominique Chevalier (D)

Department of Ear, Nose, Throat-Head and Neck Surgery, Huriez Hospital, University of Lille, Lille, France.

Ryan K Orosco (RK)

Department of Surgery, Division of Head and Neck Surgery, University of California San Diego, La Jolla, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH